Delivery Order SPE2DB24D8003-SPE2DB25FJTTT
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,778.75 to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTOR medication and has a completion date of May 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows Dakota Drug, Inc. to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order valued at $2,528.44 and has a firm fixed price pricing type. It is not a set-aside contract. The contract is for the provision of pharmaceutical products, specifically Aimovig 140 mg/ml autoinjectors, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with...
This is a $3,035.10 firm fixed-price delivery order (SPE2DX15D8003|SPE2DX24F7C7D) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a period of performance through February 12, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,046.23, is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a firm fixed price pricing type and a performance period ending on March 25, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
This is a $1,532.07 firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of AIMOVIG 70 MG/ML autoinjectors, a pharmaceutical product, with a performance period through November 25, 2024. This award is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop...
This federal contract award, valued at $4,370.30, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. This appears to be a stand-alone delivery order contract, not associated with a larger contract vehicle. The contract has a firm fixed-price pricing structure and does not utilize a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product Aimovig 70 mg/ml autoinjector. The contract has a ceiling value of $1,866.28 and a period of performance through April 22, 2024. This award is not associated with a set-aside designation. Dakota Drug, Inc. has over two decades of experience providing a wide range...
This federal contract award, identified as SPE2DB24D8001 and SPE2DB25FKZHX, was granted by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order valued at $1,667.25 with a Firm Fixed Price pricing type and an ultimate completion date of March 10, 2025. The contract is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to support the medical operations of the U.S. Armed Forces....
This firm fixed-price delivery order contract was awarded by the Department of Defense (DoD), specifically the Defense Logistics Agency (DLA) Troop Support Medical, to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $2,717.38, is for the supply of the prescription medication AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of May 14, 2024 and was awarded on May 13, 2024...
Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order valued at $1,739.42 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Issued against an existing blanket purchase agreement with no set-aside designation, this delivery order provides for AIMOVIG 70 MG/ML autoinjectors to fulfill requirements in support of DLA Troop Support Medical supply chain...